| Trial-Results center | |||
| Clinical trial results database |
 Feedback
 Home
|
Systematic review and meta-analysis
This trial is included in the following systematic reviews and meta-analyses:
post acute coronary syndromes
-
antithrombotics
-
all type of patients
post myocardial infarction
-
antithrombotics
-
all type of patients
Related trials
See also:
REDEEM study, 2009 |
|
| [NCT00621855] unpublished (or not yet fully published) trial |
Tweet
Facebook
 pdf :
dabigatran
-
antithrombotics for post acute coronary syndromes
|
Treatments
| Studied treatment |
dabigatran 4 dosages (50mg twice daily, 75mg twice daily, 110mg twice daily, 150mg twice daily)
|
| Control treatment |
placebo
|
| Concomittant treatment | aspirin and clopidogrel |
| Remarks | 5 arms: dabigatran 50 mg twice daily (n=372), 75 mg twice daily (n=371), 110 mg twice daily (n=411), 150 mg twice daily (n=351), or placebo (n=373) |
Patients
| Patients | patients with recent acute coronary syndromes (ST- or non-ST-elevation myocardical infarction) | ||||
| Baseline characteristics |
|
Method and design
| Randomized effectives | 1501 / 373 (studied vs. control) |
| Design | Parallel groups |
| Blinding | double blind |
| Follow-up duration | 6 months |
| Primary endpoint | Major and minor bleeding |
Results
No results available for this trial - unpublished or not fully published trial
Meta-analysis of all similar trials:
antithrombotics in post acute coronary syndromes for all type of patients
antithrombotics in post myocardial infarction for all type of patients
Reference(s)
| Trials register # | NCT00621855 |
unpublished (or not yet fully published) trial
(c) 2004-2011 TrialResults-center - All Rights Reserved
Tweet this
notify a friend